These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Changes in renal function during reactive phases of lepromatous leprosy. Thomas G; Karat AB; Rao PS; Prathapkumar C Int J Lepr Other Mycobact Dis; 1970; 38(2):170-6. PubMed ID: 5529247 [No Abstract] [Full Text] [Related]
8. Alpha-1-antitrypsin in leprosy. Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987 [TBL] [Abstract][Full Text] [Related]
9. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins. Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968 [TBL] [Abstract][Full Text] [Related]
10. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695 [TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975 [TBL] [Abstract][Full Text] [Related]
12. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157 [TBL] [Abstract][Full Text] [Related]
13. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
15. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. Gupta N; Shankernarayan NP; Dharmalingam K J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739 [TBL] [Abstract][Full Text] [Related]
16. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum. Sasiain MC; Ruibal Ares B; BaliƱa LM; Valdez R; Bachmann AE Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570 [TBL] [Abstract][Full Text] [Related]
17. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum. Foss NT; de Oliveira EB; Silva CL Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031 [TBL] [Abstract][Full Text] [Related]
18. Pupil cycle time in leprosy patients without clinically apparent ocular pathology. Daniel E; Rao PS Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):529-34. PubMed ID: 8642215 [TBL] [Abstract][Full Text] [Related]
19. Renal manifestations of leprosy: glomerulonephritis, a complication of erythema nodosum leprosum. Drutz DJ; Gutman RA Am J Trop Med Hyg; 1973 Jul; 22(4):496-502. PubMed ID: 4717692 [No Abstract] [Full Text] [Related]
20. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL). Sharma VK; Saha K; Sehgal VN Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]